🔎 Trials Near Me

Beranda › Gangguan Depresi Mayor › Virginia

Uji klinis Gangguan Depresi Mayor di Virginia

7 studi untuk Gangguan Depresi Mayor mencari peserta di lokasi di Virginia.

Kota di Virginia

Teks studi resmi (Bahasa Inggris)

A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor

  • Neurocrine Clinical Site, Richmond
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT07105111

Evaluating Conversational Artificial Intelligence for Depression Management

  • George Mason University, Fairfax
Menerima peserta
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07105397

NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Charlottesville
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT06911112

A Study of Brenipatide in Adult Participants With Major Depressive Disorder

  • Re:Cognition Health, Fairfax
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 6 Agu 2026 · NCT07412756

A Study to Evaluate the Maintenance Effect of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

  • Neurocrine Clinical Site, Roanoke
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT07196501

Study of ABX-002 for the Adjunctive Treatment of Major Depressive Disorder (AMPLIFY)

  • Autobahn Site #145, Fairfax
Menerima pesertaFase 2
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 20 Jan 2026 · NCT06633016

Study of ALTO-300 in MDD

  • Site 211, Roanoke
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 24 Jul 2025 · NCT05922878

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.